KDL Inc.
Industry · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Unknown | A Dose Escalation Study of VS-505 in End Stage Renal Disease Patients Undergoing Hemodialysis End Stage Renal Disease, Hyperphosphatemia | Phase 1 / Phase 2 | 2015-06-01 |
| Completed | A Study of HS219 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia Hyperphosphatemia, Chronic Kidney Disease | Phase 2 | 2009-12-01 |